Fig. 3: Progression-free survival of participants treated with BMS-98654.
Kaplan-Meier curve displaying progression free survival for participants treated with BMS-98654 at the recommended phase 2 dose (RP2D).
Fig. 3: Progression-free survival of participants treated with BMS-98654. | Leukemia
